Metraipolis › archive › dc_5424208eebb7

Pharmacokinetics and safety comparison of cycloserine capsules and their generic counterpart: a randomized, open-label, two-period, two-sequence, single-dose… — Europe PMC PMID:42741472

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42741472
DOI
10.3389/fphar.2026.1801953
License (as archived)
solo-consultazione
Archived
2026-10-09T23:20:02.052Z
SHA-256 of the archived text
965a6b724dd93ccc428a6cef9cfc8e71d025aab492ee10ce5a6675b653348780
Stable URL of this page
https://metraipolis.com/documento/dc_5424208eebb7

How to cite

Pharmacokinetics and safety comparison of cycloserine capsules and their generic counterpart: a randomized, open-label, two-period, two-sequence, single-dose… — Europe PMC PMID:42741472 — Europe PMC (en), https://europepmc.org/article/MED/42741472 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5424208eebb7 (Metraipolis archive dc_5424208eebb7, sha256 965a6b724dd93ccc428a6cef9cfc8e71d025aab492ee10ce5a6675b653348780)
BibTeX
@misc{dc5424208eebb7,
  title = {Pharmacokinetics and safety comparison of cycloserine capsules and their generic counterpart: a randomized, open-label, two-period, two-sequence, single-dose… — Europe PMC PMID:42741472},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42741472},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5424208eebb7; sha256 965a6b724dd93ccc428a6cef9cfc8e71d025aab492ee10ce5a6675b653348780},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42741472. Agents can read the archived copy with the MCP tool read_document.